Endo Counts On Vasostrict Revenues Despite Competition

As Company Focuses On ‘Optimizing’ Its Generics Business

 
• By Akriti Seth
  
strategy
Endo lays out its three-year strategy • Source: Alamy

More from Generics

More from Products